{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:03:24Z","timestamp":1778814204487,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Scientific Research Projects of Universities in Zhejiang Province","award":["Y201430629"],"award-info":[{"award-number":["Y201430629"]}]},{"name":"Huzhou Nonprofit Technological Application Research Project","award":["2017GY39"],"award-info":[{"award-number":["2017GY39"]}]},{"name":"Huzhou Nonprofit Technological Application Research Project","award":["2018GYB320"],"award-info":[{"award-number":["2018GYB320"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s10096-021-04188-4","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T14:04:13Z","timestamp":1614607453000},"page":"1599-1608","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study"],"prefix":"10.1007","volume":"40","author":[{"given":"Chuanfeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tangshan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonghua","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongtan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Cram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1812-2674","authenticated-orcid":false,"given":"Linfu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"issue":"Suppl 1","key":"4188_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hel.12165","volume":"19","author":"LH Eusebi","year":"2014","unstructured":"Eusebi LH, Zagari RM, Bazzoli F (2014) Epidemiology of Helicobacter pylori infection. Helicobacter 19(Suppl 1):1\u20135. https:\/\/doi.org\/10.1111\/hel.12165","journal-title":"Helicobacter"},{"key":"4188_CR2","doi-asserted-by":"publisher","first-page":"481365","DOI":"10.1155\/2014\/481365","volume":"2014","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Zhou X, Wu J, Su J, Zhang G (2014) Risk factors and prevalence of Helicobacter pylori infection in persistent high incidence area of gastric carcinoma in Yangzhong City. Gastroenterol Res Pract 2014:481365. https:\/\/doi.org\/10.1155\/2014\/481365","journal-title":"Gastroenterol Res Pract"},{"key":"4188_CR3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","volume":"64","author":"K Sugano","year":"2015","unstructured":"Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P, faculty members of Kyoto Global Consensus C (2015) Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64:1353\u20131367. https:\/\/doi.org\/10.1136\/gutjnl-2015-309252","journal-title":"Gut"},{"key":"4188_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ijc.28999","volume":"136","author":"M Plummer","year":"2015","unstructured":"Plummer M, Franceschi S, Vignat J, Forman D, de Martel C (2015) Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer 136:487\u2013490. https:\/\/doi.org\/10.1002\/ijc.28999","journal-title":"Int J Cancer"},{"key":"4188_CR5","unstructured":"Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994 (1994). IARC Monogr Eval Carcinog Risks Hum 61:1-241"},{"key":"4188_CR6","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1111\/j.1572-0241.2004.40014.x","volume":"99","author":"AC Ford","year":"2004","unstructured":"Ford AC, Delaney BC, Forman D, Moayyedi P (2004) Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol 99:1833\u20131855. https:\/\/doi.org\/10.1111\/j.1572-0241.2004.40014.x","journal-title":"Am J Gastroenterol"},{"issue":"1113-1124","key":"4188_CR7","doi-asserted-by":"publisher","first-page":"e1115","DOI":"10.1053\/j.gastro.2016.01.028","volume":"150","author":"YC Lee","year":"2016","unstructured":"Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY (2016) Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 150(1113-1124):e1115. https:\/\/doi.org\/10.1053\/j.gastro.2016.01.028","journal-title":"Gastroenterology"},{"key":"4188_CR8","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1136\/gut.2003.022111","volume":"53","author":"F M\u00e9graud","year":"2004","unstructured":"M\u00e9graud F (2004) H pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut 53:1374\u20131384. https:\/\/doi.org\/10.1136\/gut.2003.022111","journal-title":"Gut"},{"key":"4188_CR9","doi-asserted-by":"publisher","first-page":"e12475","DOI":"10.1111\/hel.12475","volume":"23","author":"WZ Liu","year":"2018","unstructured":"Liu WZ, Xie Y, Lu H, Cheng H, Zeng ZR, Zhou LY, Chen Y, Wang JB, Du YQ LNH, Chinese Society of Gastroenterology CSGoHp, Peptic U (2018) Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection. Helicobacter 23:e12475. https:\/\/doi.org\/10.1111\/hel.12475","journal-title":"Helicobacter"},{"key":"4188_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-3-0348-8105-0_15","volume-title":"Macrolide antibiotics","author":"F M\u00e9graud","year":"2002","unstructured":"M\u00e9graud F (2002) Helicobacter pylori and macrolides. In: Sch\u00f6nfeld W, Kirst HA (eds) Macrolide antibiotics. Milestones in drug therapy MDT. Birkh\u00e4user, Basel, pp 243\u2013260. https:\/\/doi.org\/10.1007\/978-3-0348-8105-0_15"},{"key":"4188_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1128\/aac.39.1.107","volume":"39","author":"RA Moore","year":"1995","unstructured":"Moore RA, Beckthold B, Wong S, Kureishi A, Bryan LE (1995) Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother 39:107\u2013111. https:\/\/doi.org\/10.1128\/aac.39.1.107","journal-title":"Antimicrob Agents Chemother"},{"key":"4188_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.meegid.2016.06.044","volume":"44","author":"J Alarcon-Millan","year":"2016","unstructured":"Alarcon-Millan J, Fernandez-Tilapa G, Cortes-Malagon EM, Castanon-Sanchez CA, De Sampedro-Reyes J, Cruz-Del Carmen I, Betancourt-Linares R, Roman-Roman A (2016) Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern Mexico with chronic gastritis. Infect Genet Evol 44:190\u2013198. https:\/\/doi.org\/10.1016\/j.meegid.2016.06.044","journal-title":"Infect Genet Evol"},{"key":"4188_CR13","doi-asserted-by":"publisher","first-page":"e12634","DOI":"10.1111\/hel.12634","volume":"24","author":"JH Nahm","year":"2019","unstructured":"Nahm JH, Kim WK, Kwon Y, Kim H (2019) Detection of Helicobacter pylori with clarithromycin resistance-associated mutations using peptide nucleic acid probe-based melting point analysis. Helicobacter 24:e12634. https:\/\/doi.org\/10.1111\/hel.12634","journal-title":"Helicobacter"},{"key":"4188_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1128\/jcm.41.1.397-402.2003","volume":"41","author":"M Oleastro","year":"2003","unstructured":"Oleastro M, Menard A, Santos A, Lamouliatte H, Monteiro L, Barthelemy P, Megraud F (2003) Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J Clin Microbiol 41:397\u2013402. https:\/\/doi.org\/10.1128\/jcm.41.1.397-402.2003","journal-title":"J Clin Microbiol"},{"key":"4188_CR15","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1523-5378.2011.00840.x","volume":"16","author":"JW Lee","year":"2011","unstructured":"Lee JW, Kim N, Nam RH, Park JH, Kim JM, Jung HC, Song IS (2011) Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea. Helicobacter 16:301\u2013310. https:\/\/doi.org\/10.1111\/j.1523-5378.2011.00840.x","journal-title":"Helicobacter"},{"key":"4188_CR16","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/jac\/dky167","volume":"73","author":"M Bachir","year":"2018","unstructured":"Bachir M, Allem R, Benejat L, Tifrit A, Medjekane M, Drici AE, Megraud F, Douidi KT (2018) Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria. J Antimicrob Chemother 73:2034\u20132038. https:\/\/doi.org\/10.1093\/jac\/dky167","journal-title":"J Antimicrob Chemother"},{"key":"4188_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/jac\/31.1.65","volume":"31","author":"G Cederbrant","year":"1993","unstructured":"Cederbrant G, Kahlmeter G, Ljungh A (1993) The E test for antimicrobial susceptibility testing of Helicobacter pylori. J Antimicrob Chemother 31:65\u201371. https:\/\/doi.org\/10.1093\/jac\/31.1.65","journal-title":"J Antimicrob Chemother"},{"key":"4188_CR18","doi-asserted-by":"publisher","unstructured":"Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y; Study Group participants (2013) Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut 62 :34-42. doi:https:\/\/doi.org\/10.1136\/gutjnl-2012-302254","DOI":"10.1136\/gutjnl-2012-302254"},{"key":"4188_CR19","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/jgh.14980","volume":"35","author":"G Yin","year":"2020","unstructured":"Yin G, Bie S, Gu H, Shu X, Zheng W, Peng K, Zhao H, Li F, Chen B, Botchway BOA, Fang M, Jiang M (2020) Application of gene chip technology in the diagnostic and drug resistance detection of Helicobacter pylori in children. J Gastroenterol Hepatol 35:1331\u20131339. https:\/\/doi.org\/10.1111\/jgh.14980","journal-title":"J Gastroenterol Hepatol"},{"key":"4188_CR20","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1093\/nar\/17.7.2503","volume":"17","author":"CR Newton","year":"1989","unstructured":"Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF (1989) Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 17:2503\u20132516. https:\/\/doi.org\/10.1093\/nar\/17.7.2503","journal-title":"Nucleic Acids Res"},{"key":"4188_CR21","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/cam4.1986","volume":"8","author":"XY Zhang","year":"2019","unstructured":"Zhang XY, Shen WX, Chen CF, Sheng HH, Cheng H, Li J, Hu F, Lu DR, Gao HJ (2019) Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real-time PCR. Cancer Med 8:1633\u20131640. https:\/\/doi.org\/10.1002\/cam4.1986","journal-title":"Cancer Med"},{"key":"4188_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13099-020-00373-623","volume":"12","author":"Y Li","year":"2020","unstructured":"Li Y, Lv T, He C, Wang H, Cram DS, Zhou L, Zhang J, Jiang W (2020) Evaluation of multiplex ARMS-PCR for detection of Helicobacter pylori mutations conferring resistance to clarithromycin and levofloxacin. Gut Pathog 12:35. https:\/\/doi.org\/10.1186\/s13099-020-00373-623","journal-title":"Gut Pathog"},{"key":"4188_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.diagmicrobio.2016.03.001","volume":"87","author":"JJ Aguilera-Correa","year":"2017","unstructured":"Aguilera-Correa JJ, Urruzuno P, Barrio J, Martinez MJ, Agudo S, Somodevilla A, Llorca L, Alarcon T (2017) Detection of Helicobacter pylori and the genotypes of resistance to clarithromycin and the heterogeneous genotype to this antibiotic in biopsies obtained from symptomatic children. Diagn Microbiol Infect Dis 87:150\u2013153. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2016.03.001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4188_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","volume":"66","author":"P Malfertheiner","year":"2017","unstructured":"Malfertheiner P, Megraud F, O\u2019Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM, European H, Microbiota Study G, Consensus p (2017) Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report. Gut 66:6\u201330. https:\/\/doi.org\/10.1136\/gutjnl-2016-312288","journal-title":"Gut"},{"key":"4188_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fcimb.2017.00168","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu Y, Zhu Y, Lu NH (2017) Novel and effective therapeutic regimens for Helicobacter pylori in an Era of increasing antibiotic resistance. Front Cell Infect Microbiol 7:168. https:\/\/doi.org\/10.3389\/fcimb.2017.00168","journal-title":"Front Cell Infect Microbiol"},{"issue":"1372-1382","key":"4188_CR26","doi-asserted-by":"publisher","first-page":"e1317","DOI":"10.1053\/j.gastro.2018.07.007","volume":"155","author":"A Savoldi","year":"2018","unstructured":"Savoldi A, Carrara E, Graham DY, Conti M, Tacconelli E (2018) Prevalence of antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis in World Health Organization Regions. Gastroenterology 155(1372-1382):e1317. https:\/\/doi.org\/10.1053\/j.gastro.2018.07.007","journal-title":"Gastroenterology"},{"key":"4188_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1523-5378.2009.00668.x","volume":"14","author":"H Cheng","year":"2009","unstructured":"Cheng H, Hu F, Zhang L, Yang G, Ma J, Hu J, Wang W, Gao W, Dong X (2009) Prevalence of Helicobacter pylori infection and identification of risk factors in rural and urban Beijing, China. Helicobacter 14:128\u2013133. https:\/\/doi.org\/10.1111\/j.1523-5378.2009.00668.x","journal-title":"Helicobacter"},{"issue":"51-69","key":"4188_CR28","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1053\/j.gastro.2016.04.006","volume":"151","author":"CA Fallone","year":"2016","unstructured":"Fallone CA, Chiba N, van Zanten SV, Fischbach L, Gisbert JP, Hunt RH, Jones NL, Render C, Leontiadis GI, Moayyedi P, Marshall JK (2016) The Toronto consensus for the treatment of Helicobacter pylori infection in adults. Gastroenterology 151(51-69):e14. https:\/\/doi.org\/10.1053\/j.gastro.2016.04.006","journal-title":"Gastroenterology"},{"key":"4188_CR29","doi-asserted-by":"publisher","first-page":"e01834","DOI":"10.1128\/JCM.01834-18","volume":"57","author":"BG Nezami","year":"2019","unstructured":"Nezami BG, Jani M, Alouani D, Rhoads DD, Sadri N (2019) Helicobacter pylori mutations detected by next-generation sequencing in formalin-fixed, paraffin-embedded gastric biopsy specimens are associated with treatment failure. J Clin Microbiol 57:e01834\u2013e01818. https:\/\/doi.org\/10.1128\/JCM.01834-18","journal-title":"J Clin Microbiol"},{"key":"4188_CR30","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1128\/AAC.04852-14","volume":"59","author":"TT Binh","year":"2015","unstructured":"Binh TT, Suzuki R, Trang TT, Kwon DH, Yamaoka Y (2015) Search for novel candidate mutations for metronidazole resistance in Helicobacter pylori using next-generation sequencing. Antimicrob Agents Chemother 59:2343\u20132348. https:\/\/doi.org\/10.1128\/AAC.04852-14","journal-title":"Antimicrob Agents Chemother"},{"key":"4188_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.5009\/gnl18111","volume":"12","author":"DH Jung","year":"2018","unstructured":"Jung DH, Kim JH, Jeong SJ, Park SY, Kang IM, Lee KH, Song YG (2018) Peptide nucleic acid probe-based analysis as a new detection method for clarithromycin resistance in Helicobacter pylori. Gut Liver 12:641\u2013647. https:\/\/doi.org\/10.5009\/gnl18111","journal-title":"Gut Liver"},{"key":"4188_CR32","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ijantimicag.2006.11.007","volume":"29","author":"V Cattoir","year":"2007","unstructured":"Cattoir V, Nectoux J, Lascols C, Deforges L, Delchier JC, Megraud F, Soussy CJ, Cambau E (2007) Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. Int J Antimicrob Agents 29:389\u2013396. https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.11.007","journal-title":"Int J Antimicrob Agents"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04188-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04188-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T14:45:46Z","timestamp":1626878746000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04188-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["4188"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04188-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"assertion":[{"value":"15 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TL, HW, and XL are employees of Zhejiang Mole Biological Technology Co., Ltd and hold no stocks or bonds. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Approval was obtained from the ethics committee of the First Affiliated Hospital of Nanchang University, Nanfang Hospital of Southern Medical University, and Huzhou Central Hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}